|Articles|October 1, 2011
- Pharmaceutical Executive-10-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - October 2011
Thirty Years of Pharm Exec
Advertisement
Articles in this issue
about 14 years ago
Y. K Hamied : Changing the Dialogueabout 14 years ago
Fred Frank: Fortune and the Financierabout 14 years ago
Marck McLellan: An 'A' for Advancing Expectationsabout 14 years ago
Inside the Mind of the CEO: Steve Collisabout 14 years ago
Atsushi Nagahisa: Creating Customer Valueabout 14 years ago
Physicians: Still the Vital Connection in Medicineabout 14 years ago
Henry Waxman: "Representing" Healthcare to the Fullestabout 14 years ago
IP: Securing a Global Consensus—Can Industry Do It Again?about 14 years ago
In Establishing the Evidence Base, He Made Science Countabout 14 years ago
Jane Henney: Lessons from the FDA Front LineNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Bristol Myers Squibb Enters $1.5 Billion Definitive Agreement Acquiring Orbital Therapeutics
2
AstraZeneca to Announce Deal with Trump Administration: Report
3
Ypsomed Announces New U.S.-Based Manufacturing Site in North Carolina
4
Pharmaceutical Executive Daily: Most Favored Nation Order's Evolving Landscape
5
